–
Zentalis Pharmaceuticals, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
millions USD
FY21:
FY22:
–
FY23:
–
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−217
FY22:
−227
FY23:
−300
FY24:
−191
FY25:
−153
(positive)
Change from FY21 to FY22
millions USD
FY21:
−268
FY22:
−232
FY23:
–
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−166
FY22:
−238
FY23:
−293
FY24:
−166
FY25:
−137
(positive)
Change from FY21 to FY25
millions USD
FY21:
−159
FY22:
−237
FY23:
−292
FY24:
−166
FY25:
−137
All amounts in millions USD